^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

GZ402663

i
Other names: GZ402663, sFLT01, anti vascular endothelial growth factor (VEGF) gene therapy, AAV2sFLT 01, AAV2-sFLT01, GZ-402663
Associations
Trials
Company:
AGTC, Sanofi
Drug class:
VEGF-A inhibitor, Gene transference, PIGF inhibitor
Related drugs:
Associations
Trials